Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 536

1.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
2.
3.
4.

Pantoprazole.

Poole P.

Am J Health Syst Pharm. 2001 Jun 1;58(11):999-1008. Review.

PMID:
11402494
5.

The proton-pump inhibitors: similarities and differences.

Horn J.

Clin Ther. 2000 Mar;22(3):266-80; discussion 265. Review.

PMID:
10963283
6.

Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR.

Am J Gastroenterol. 2001 Dec;96(12):3274-80.

PMID:
11774936
7.

Pantoprazole: a new proton pump inhibitor.

Jungnickel PW.

Clin Ther. 2000 Nov;22(11):1268-93. Review.

PMID:
11117653
8.

An overview of proton pump inhibitors.

Der G.

Gastroenterol Nurs. 2003 Sep-Oct;26(5):182-90. Review.

PMID:
14603076
9.
10.

Formulary management of proton pump inhibitors.

Byrne MF, Murray FE.

Pharmacoeconomics. 1999 Sep;16(3):225-46. Review.

PMID:
10558037
12.
13.

The use of proton pump inhibitors in children: a comprehensive review.

Gibbons TE, Gold BD.

Paediatr Drugs. 2003;5(1):25-40. Review.

PMID:
12513104
14.

Lansoprazole: a comprehensive review.

Zimmermann AE, Katona BG.

Pharmacotherapy. 1997 Mar-Apr;17(2):308-26. Review.

PMID:
9085323
15.

Switching between intravenous and oral pantoprazole.

Pisegna JR.

J Clin Gastroenterol. 2001 Jan;32(1):27-32. Review.

PMID:
11154164
16.

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Miner P Jr, Katz PO, Chen Y, Sostek M.

Am J Gastroenterol. 2003 Dec;98(12):2616-20.

PMID:
14687806
17.

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Fitton A, Wiseman L.

Drugs. 1996 Mar;51(3):460-82. Review. Erratum in: Drugs 1996 Jun;51(6):1074. Drugs 1996 Jul;52(1):92.

PMID:
8882382
18.

Lansoprazole: an update of its place in the management of acid-related disorders.

Matheson AJ, Jarvis B.

Drugs. 2001;61(12):1801-33. Review.

PMID:
11693467
19.

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Andersson T.

Clin Pharmacokinet. 1996 Jul;31(1):9-28. Review. Erratum in: Clin Pharmacokinet 1996 Oct;31(4):274.

PMID:
8827397

Supplemental Content

Support Center